| mTOR inhibition in advanced renal cell carcinoma: Which criteria should be ... - UroToday |
|
|
UroToday With the implementation of mammalian target of rapamycin (mTOR) inhibitors in the systemic treatment of advanced renal cell carcinoma (RCC), |